Effect of maternal antibodies on the infant immune response

Vaccine

Volumn 21, Issue 24, 2003, Pages 3389-3392

  Glezen, W Paul ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Infant immunity; Maternal antibodies; Vaccine response

Indexed keywords

ANTIBODY; DIPHTHERIA VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MENINGOCOCCUS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE;

ACTIVE IMMUNIZATION; ANTIBODY RESPONSE; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFLUENZA VIRUS; MULTICENTER STUDY; PARAINFLUENZA VIRUS; PHASE 2 CLINICAL TRIAL; PLACENTAL TRANSFER; POLIOMYELITIS; PREGNANCY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION;

EID: 0038722334     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00339-6     Document Type: Conference Paper

References (29)

1. Glezen W.P. Maternal vaccines. Primary Care: Clin. Office Pract. 28:2001;791-806.
2. Puck J.M., Glezen W.P., Frank A.L., Six H.R. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J. Infect. Dis. 142:1980;844-849.
3. Glezen W.P., Paredes A., Allison J.E., Taber L.H., Frank A.L. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J. Pediatr. 98:1981;708-715.
4. Glezen W.P., Frank A.L., Taber L.H., Kasel J.A. Parainfluenza virus type 3: seasonality and risk of infection and re-infection in young children. J. Infect. Dis. 150:1984;851-857.
5. Crowe J.E. Jr. Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines. Vaccine. 16:1998;1423-1432.
6. Glezen W.P., Taber L.H., Frank A.L., Kasel J.A. Risk of primary infection and re-infection with respiratory syncytial virus. Am. J. Dis. Child. 140:1986;543-546.
7. Kasel J.A., Frank A.L., Keitel W.A., Taber L.H., Glezen W.P. Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus type 3 in children. J. Virol. 52:1984;828-832.
8. Frank A.L., Taber L.H., Glezen W.P., Paredes A., Couch R.B. Reinfection with influenza A (H3N2) virus in young children and their families. J. Infect. Dis. 140:1979;829-836.
9. Englund J.A., Anderson E.L., Reed G.F.et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics. 96:1995;580-584.
10. Warren R.J., Lepow M.L., Bartsch G.E., Robbins F.C. The relationship of maternal antibody, breast feeding, and age to the susceptibility of newborn infants to infection with attenuated polioviruses. Pediatrics. 34:1964;4-13.
11. Simoes E.A.F., Padmini B., Steinhoff M.C., Jadhav M., John T.J. Antibody response of infants to two doses of inactivated poliovirus vaccine of enhanced potency. Am. J. Dis. Child. 139:1985;977-980.
12. Kurikka S., Kayhty H., Peltola H., Saarinen L., Eskola J., Makela P.H. Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatrics. 95:1995;815-822.
13. Kurikka S. Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenzae type b-tetanus conjugate vaccine in infancy. Vaccine. 14:1996;1239-1242.
14. Booy R., Taylor S.A., Dobson S.R.M.et al. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunization schedule. Arch. Dis. Child. 67:1992;475-478.
15. Claesson B.A., Schneerson R., Robbins J.B.et al. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. J. Pediatr. 114:1989;97-100.
16. Greenberg D.P., Vadheim C.M., Partridge S.et al. Immunogenicity of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in oung infants. J. Infect. Dis. 170:1994;76-81.
17. Piedra P.A., Glezen W.P., Mbawuike I.et al. Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children. Vaccine. 11:1993;718-724.
18. Crowe J.E. Jr., Bui P.T., Siber G.R.et al. Cold-passaged, termperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization. Vaccine. 13:1995;847-855.
19. Crowe J.E. Jr. Respiratory syncytial virus vaccine development. Vaccine. 20:2002;S32-S37.
20. Clements M.L., Makhene M.K., Karron R.A.et al. Effective immunization with live attenuated influenza A virus can be achieved in early infancy. J. Infect. Dis. 173:1996;44-51.
21. Gans H.A., Arvin A.M., Galinus J., Logan L., DeHovitz R., Maldonado Y. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA. 280:1998;527-532.
22. Karron R.A., Steinhoff M.C., Subbarao E.K.et al. Safety and immunogenicity of a cold-adapted influenza A(H1N1) reassortant virus vaccine administered to infants less than 6 months of age. Pediatr. Infect. Dis. J. 14:1995;10-16.
23. Bjorkholm B., Granstrom M., Taranger J., Wahl M., Hagberg L. Influence of high titers of maternal antibody on the serologic response of infants to diphtheria vaccination of 3, 5 and 12 months of age. Pediatr. Infect. Dis. J. 14:1995;846-850.
24. Nohynek H., Gustafsson L., Capeding M.R.Z.et al. Effect of transplacentally acquired tetanus antibodies on the antibody responses to Haemophilus influenzae type b-tetanus toxoid conjugate and tetanus toxoid vaccines in Filipino infants. Pediatr. Infect. Dis. J. 18:1999;25-30.
25. McCormick J.B., Gusmao H.H., Nakamura S.et al. Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born to mothers vaccinated during pregnancy. J. Clin. Invest. 65:1980;1141-1144.
26. Amstey M.S., Insel R., Munoz J., Pichichero M. Fetal-neonatal passive immunization against Haemophilus influenzae, type b. Am. J. Obstet. Gynecol. 155:1985;607-611.
27. Englund J.A., Glezen W.P., Thompson C., Anwaruddin R., Turner C.S., Siber G.R. Haemophilus influenzae type b-specific antibody in infants after maternal immunization. Pediatr. Infect. Dis. J. 16:1997;1122-1130.
28. Mulholland K., Suara R.O., Siber G.R.et al. Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein-conjugate vaccine in The Gambia. JAMA. 275:1996;1182-1188.
29. Santosham M., Englund J.A., McInnes P.et al. Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants. Pediatr. Infect. Dis. J. 20:2001;931-940.